Clinical Trial Detail

NCT ID NCT03839342
Title Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations (BEAVER)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

Advanced Solid Tumor

Therapies

Binimetinib + Encorafenib

Age Groups: senior adult

Additional content available in CKB BOOST